Goldman Sachs and Evercore ISI analysts have raised price targets for GE HealthCare Technologies (GEHC), citing a projected market recovery and strong capital expenditure trends by 2026. The medical devices firm is highlighted as a top hedge fund pick.
Boston Scientific (BSX) is attracting bullish analyst attention after its strategic acquisition of Penumbra, with Truist Securities reiterating a Buy rating and a $120 price target, citing enhanced business durability and growth prospects.
A recent physician survey on renal denervation procedure volumes has prompted analysts to adopt a more measured view of Medtronic's near-term growth potential, even as the medical device giant remains a favored long-term holding.
Driven by falling costs and strong incentives, heavy manufacturing is increasingly turning to on-site solar power. This shift is transforming large factory roofs from passive structures into strategic assets for cutting energy bills and emissions.
Allegro MicroSystems (ALGM) reported strong fourth-quarter results, with revenue surging 29% year-over-year to $229.2 million, surpassing analyst expectations. The chip designer's growth was fueled by record data center sales and robust demand in automotive, particularly for electric vehicles and ADAS.
While Booz Allen Hamilton's Q4 revenue fell short of expectations, robust profitability and a strategic shift toward outcome-based contracts in high-demand sectors like cybersecurity spurred investor optimism. Analysts pressed management on the sustainability of this model and the path forward in a complex funding environment.
Bread Financial (NYSE: BFH) posted a mixed fourth quarter, with revenue falling short of expectations but adjusted earnings soaring past estimates. The company credits its disciplined operational focus and expanding product portfolio for the profit strength, even as it navigates a softer top-line environment.
Usama Ghanem, an Egyptian student at King's College London, faces imminent deportation after disciplinary action linked to his pro-Palestinian activism. He claims the university's response mirrors the political persecution he fled in Egypt, raising urgent questions about academic freedom and the treatment of international dissent.
Nelnet (NNI) reaffirms its commitment to shareholders with a steady dividend, backed by strong historical revenue growth and share buybacks. Yet, a closer look reveals a complex valuation picture, with contrasting signals from its P/E ratio and discounted cash flow model, leaving analysts divided on the stock's true worth.
Novo Nordisk charts a bold new course, launching a pivotal oral obesity drug while restructuring its workforce and deepening its investment in next-generation cell therapies for metabolic diseases.
Walmart announces CEO Doug McMillon's retirement, appointing tech veterans John Furner and David Guggina to lead its next chapter. The move underscores the retail giant's intensified focus on digital transformation amid strong shareholder returns.
Barclays' upgrade of PTC Therapeutics to Overweight has spotlighted the biotech firm's valuation, with shares showing strong momentum but questions lingering over its path to profitability and reliance on a narrow drug portfolio.
Applied Optoelectronics (AAOI) has secured a significant order for its high-speed 800G optical transceivers from a key hyperscale client, coinciding with a strategic expansion of its Texas manufacturing facility to meet surging AI data center demand.
Deere & Company is doubling down on American manufacturing with a new excavator plant and parts center, part of a broader $20 billion commitment. While the move strengthens its long-term industrial narrative, near-term challenges from leadership changes to cyclical market pressures remain in focus.
Sanofi announces promising late-stage results for its immunology candidate amlitelimab and expands into genetic therapies via an investment in Sensorion, signaling a strategic push into high-value therapeutic areas.
South Plains Financial (NASDAQ: SPFI) announces an increased quarterly dividend to $0.17 per share, reflecting strong earnings growth and a conservative payout strategy. While the yield remains modest, analysts highlight the company's potential for sustained dividend expansion.
A historic rally in gold and silver reversed violently on Friday, with gold futures plummeting over 10% in their sharpest decline since the 1980s and silver recording its largest single-day drop ever, amid a broader market sell-off.
CNBC's Jim Cramer questions Meta's direction, citing investor skepticism over its AI strategy and spending. Yet strong Q4 earnings reveal a more complex financial picture, sparking debate on Wall Street.
Crude oil and gasoline prices advanced on Friday, supported by persistent geopolitical risks in the Middle East and ongoing supply constraints, though gains were tempered by a stronger dollar and diplomatic signals.
After selling her fitness platform Sweat for $400 million, entrepreneur Kayla Itsines reveals her most reliable cash flow comes from an unexpected asset: a petrol station. The self-made millionaire advocates for diversification beyond the digital realm.
